Stay updated on Moderna Press Releases
Sign up to get notified when there's something new on the Moderna Press Releases page.

Latest updates to the Moderna Press Releases page
- CheckyesterdayChange DetectedAdded a new press release entry for ESCMID 2026: 'Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA' (April 6, 2026). Removed the earlier press release about Moderna's collaboration with Recordati on mRNA-3927 (January 29, 2026).SummaryDifference1%

- Check8 days agoChange DetectedNew 2026 press releases and dates are added to the News and Blog Posts section (e.g., Moderna Resolves Global Patent Litigation with Arbutus/Genevant, Feb–Mar 2026). Several navigation items, including About Us and Stock Info, were removed.SummaryDifference11%

- Check15 days agoChange DetectedStock price and trading volume were updated on the page. A large portion of press releases and related navigation items appear to have been removed.SummaryDifference6%

- Check22 days agoChange DetectedHeader stock ticker updated from NASD: MRNA $55.80 Vol: 4.57M to NASD: MRNA $52.37 Vol: 5.51M.SummaryDifference0.5%

- Check29 days agoChange DetectedStock price and trading volume on the page were updated from $52.87 and 3.18M to $55.80 and 4.57M.SummaryDifference0.9%

- Check36 days agoChange DetectedAdded new press release entries: Moderna Resolves Global Patent Litigation with Arbutus/Genevant (March 3, 2026) and EMA positive opinion for mCOMBRIAX (February 27, 2026). Updated stock data show $52.87 with 3.18M volume.SummaryDifference5%

Stay in the know with updates to Moderna Press Releases
Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.